Literature DB >> 7865319

Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors.

H A Navaline1, E C Snider, C J Petro, D Tobin, D Metzger, A I Alterman, G E Woody.   

Abstract

Our primary objective during this pilot work has been to determine if the computerized RAB can be used in place of the paper-and-pencil version with an IDU population. As stated, reliability estimates in the form of correlations of risk scores between the two versions ranged from .82 to .94, and percentages of exact agreement of the scoreable items ranged from 88% to 100%. These correlations indicate that the C-RAB is comparable to the RAB in its psychometric properties. Further, subjects' positive ratings of the computer program and perceptions that it would better protect confidentiality indicate that this population would participate in assessments involving computer interactions. While these self-reports may be biased on clients' desire to be cooperative and the novelty of the assessment approach, the high level of approval ratings suggest that a majority of participants do prefer completing assessments on the computer. Similarly, participants' demonstrated ability to use the computer and their rating of the program as easy to use suggest that the C-RAB has potential to be a reliable and efficient tool in assessing risk behaviors among IDUs enrolled in HIV vaccine trials.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865319

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  82 in total

1.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

2.  Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.

Authors:  Evgeny Krupitsky; Edwin Zvartau; Elena Blokhina; Elena Verbitskaya; Valentina Wahlgren; Marina Tsoy-Podosenin; Natalia Bushara; Andrey Burakov; Dmitry Masalov; Tatyana Romanova; Arina Tyurina; Vladimir Palatkin; Tatyana Yaroslavtseva; Anna Pecoraro; George Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-19       Impact factor: 3.829

3.  Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Patrick; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2013-08-30       Impact factor: 4.492

4.  Female Gender and HIV Transmission Risk Behaviors Among People Living with HIV Who Have Ever Used Injection Drugs in St. Petersburg, Russia.

Authors:  Jennifer A Wagman; Jeffrey H Samet; Debbie M Cheng; Natalia Gnatienko; Anita Raj; Elena Blokhina; Olga Toussova; Leah S Forman; Dmitry Lioznov; Judith I Tsui
Journal:  AIDS Behav       Date:  2018-09

5.  Associations Between Body Weight Status and Substance Use Among African American Women in Baltimore, Maryland: The CHAT Study.

Authors:  Ji Li; Cui Yang; Melissa Davey-Rothwell; Carl Latkin
Journal:  Subst Use Misuse       Date:  2016-04-06       Impact factor: 2.164

6.  Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial.

Authors:  Richard Saitz; Debbie M Cheng; Michael Winter; Theresa W Kim; Seville M Meli; Don Allensworth-Davies; Christine A Lloyd-Travaglini; Jeffrey H Samet
Journal:  JAMA       Date:  2013-09-18       Impact factor: 56.272

7.  NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.

Authors:  Joshua D Lee; Edward V Nunes; Patricia Novo Mpa; Genie L Bailey; Gregory S Brigham; Allan J Cohen; Marc Fishman; Walter Ling; Robert Lindblad; Dikla Shmueli-Blumberg; Don Stablein; Jeanine May; Dagmar Salazar; David Liu; John Rotrosen
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

8.  Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial.

Authors:  Richard Saitz; Tibor P A Palfai; Debbie M Cheng; Daniel P Alford; Judith A Bernstein; Christine A Lloyd-Travaglini; Seville M Meli; Christine E Chaisson; Jeffrey H Samet
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

9.  Complexity of childhood sexual abuse: predictors of current post-traumatic stress disorder, mood disorders, substance use, and sexual risk behavior among adult men who have sex with men.

Authors:  Michael S Boroughs; Sarah E Valentine; Gail H Ironson; Jillian C Shipherd; Steven A Safren; S Wade Taylor; Sannisha K Dale; Joshua S Baker; Julianne G Wilner; Conall O'Cleirigh
Journal:  Arch Sex Behav       Date:  2015-07-10

10.  HIV/hepatitis prevention in drug abuse treatment programs: guidance from research.

Authors:  James L Sorensen; Carmen L Masson; David C Perlman
Journal:  Sci Pract Perspect       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.